VIEWPOINT: Ruling holds promise for life sciences
It wasn’t frontpage news when the U.S. Supreme Court handed down its decision on Merck KGaA v. Integra Lifesciences earlier this summer. But among Indiana’s burgeoning life sciences sector, it should have been-n – largely because of the doors it opens (or appears to) for research-based discoveries. On June 13, the country’s highest court ruled that a “safe harbor” provision in U.S. law gives life sciences companies more freedom to use patented compounds in pre-clinical research, as long as the…